Literature DB >> 9057434

Neuroendocrine carcinoma of the larynx.

A C Curran1, N McDermott, M Leader, M Walsh.   

Abstract

A rare case of moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx is presented. The role of immunohistochemistry in the diagnosis of the lesion is described. The importance of considering the diagnosis in a patient with prolonged cervical pain with features of glossopharyngeal neuralgia, is discussed.

Entities:  

Mesh：

Year:  1997        PMID： 9057434     DOI： 10.1007/bf02939778

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  6 in total

Review 1.  Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases.

Authors:  B M Wenig; V J Hyams; D K Heffner
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

Review 2.  Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma.

Authors:  J M Woodruff; A G Huvos; R A Erlandson; J P Shah; F P Gerold
Journal:  Am J Surg Pathol       Date:  1985-11       Impact factor: 6.394

3.  Carcinoma of the larynx with mucosubstance production and neuroendocrine differentiation: an ultrastructural and immunohistochemical study.

Authors:  R R Paladugu; B N Nathwani; J Goodstein; L E Dardi; V E Memoli; V E Gould
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

Review 4.  Primary anaplastic small cell (oat cell) carcinoma of the larynx. Review of the literature and report of 18 cases.

Authors:  D R Gnepp; A Ferlito; V Hyams
Journal:  Cancer       Date:  1983-05-01       Impact factor: 6.860

5.  Primary small cell carcinoma of the larynx: analysis of treatment.

Authors:  N A Giddings; T L Kennedy; D P Vrabec
Journal:  J Otolaryngol       Date:  1987-06

Review 6.  Laryngeal paraganglioma versus atypical carcinoid tumor.

Authors:  A Ferlito; C M Milroy; B M Wenig; L Barnes; C E Silver
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-01       Impact factor: 1.547
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.